Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 26.2B | 11.8B | 11.9B | 12.2B |
Cost of revenue | 16.2B | 8.8B | 8.7B | 7.8B |
Gross profit | 10.0B | 3.0B | 3.3B | 4.5B |
Operating expense | ||||
Research & development | 275.8M | 200M | 229M | 154M |
Selling general and admin | 618.9M | 299M | 276M | 259M |
Other operating expenses | 831.7M | 1.8B | 1.2B | 2.1B |
Operating income | 8.3B | 708M | 1.6B | 2.0B |
Non operating interest income | ||||
Income | 212.8M | 148M | 78M | 18M |
Expense | 525.0M | 243M | 227M | 274M |
Other income expense | -1.6B | -2.6B | -1.5B | -632M |
Pretax income | 6.4B | -2.0B | -51M | 1.1B |
Tax provision | 2.0B | 526M | 455M | 1.1B |
Net income | 4.7B | -2.5B | -369M | 233M |
Basic EPS | 2.9 | -3.0 | -0.5 | 1.5 |
Diluted EPS | 2.9 | -3.0 | -0.5 | 1.5 |
Basic average shares | 1.6B | 591.2M | 546.3M | 549.7M |
Diluted average shares | 1.6B | 591.2M | 546.3M | 549.7M |
EBITDA | 12.1B | 3.0B | 3.9B | 4.3B |
Net income from continuing op. | 4.7B | -2.5B | -369M | 233M |
Minority interests | -33M | -27M | -60M | 933M |
Preferred stock dividends | — | — | — | — |